The Clinicopathological and Molecular Characterization in Ascites-derived Paraffin- embedded Cell Blocks of Ovarian Cancer
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
This study evaluated immunohistochemical (IHC) markers and homologous recombination repair (HRR) gene mutations in 58 ovarian cancer patients using ascites-derived paraffin-embedded cell blocks. IHC analysis revealed high expression of Pax-8 (87.5–100%), WT-1 (87.8–90%), CA-125 (100%), and CK7 (100%) across subtypes, supporting their diagnostic utility. HRR gene mutations were detected in 77.6% of cases, with TP53 (55%) and PIK3CA (21.7%) as the most frequent alterations. Nine BRCA1/2 mutations were identified. PIK3CA variants included E545K (28.6%) and E542K (28.6%), suggesting potential therapeutic targets. These findings highlight the clinical relevance of ascites cell blocks for molecular profiling, with HRR status guiding PARP inhibitor therapy and PIK3CA mutations indicating PI3K/AKT pathway inhibition. This approach may optimize personalized treatment strategies for advanced ovarian cancer.
